Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Fractyl Health (GUTS) Return on Sales (2023 - 2025)

Fractyl Health's Return on Sales history spans 3 years, with the latest figure at 32373.67% for Q3 2025.

  • For the quarter ending Q3 2025, Return on Sales fell 3074174.0% year-over-year to 32373.67%, compared with a TTM value of 32373.67% through Sep 2025, down 3157553.0%, and an annual FY2024 reading of 961.13%, down 54800.0% over the prior year.
  • Return on Sales for Q3 2025 was 32373.67% at Fractyl Health, down from 5731.76% in the prior quarter.
  • The five-year high for Return on Sales was 162.79% in Q2 2023, with the low at 32373.67% in Q3 2025.
  • Average Return on Sales over 3 years is 5022.02%, with a median of 1631.93% recorded in 2024.
  • Year-over-year, Return on Sales soared 171848bps in 2024 and then crashed -3074174bps in 2025.
  • Tracing GUTS's Return on Sales over 3 years: stood at 1788.29% in 2023, then tumbled by -356bps to 8161.33% in 2024, then crashed by -297bps to 32373.67% in 2025.
  • Per Business Quant, the three most recent readings for GUTS's Return on Sales are 32373.67% (Q3 2025), 5731.76% (Q2 2025), and 1553.28% (Q1 2025).